Advanced Tissue Sciences gains patent, strikes cosmetics deal and gets funds
This article was originally published in Clinica
Executive Summary
The State of Wisconsin Investment Board has made a $20 million private placement in Advanced Tissue Sciences. At the same time the tissue engineering company has signed a deal with a cosmetics marketer to bring its nutrient solution into a number of consumer outlets, including television home shopping channels in the US. ATS has also been granted a wide-ranging patent for the reproducible manufacture of complex three-dimensional tissue structures.
You may also be interested in...
US FDA Drugs Center Ready To Break Down Silos On Regulatory Innovation
CDER Director Cavazzoni is promising to increase coordination and collaboration to accelerate broader adoption of innovative clinical trial designs and other approaches to speed drug development. A new "Quantitative Medicine Center of Excellence" illustrates the approach.
New OSP Director To Guide CDER-Wide IT Upgrades; System Enhancements Speed ANDA Assessments
Generic Drug Structured Assessment for Bioequivalence launched in 2023 and has been used in 40 ANDA reviews so far.
New EU Approvals
The Pink Sheet's list of EU centralized approvals of new active substances has been updated to add two new products, including Ryzneuta, Evive Biotechnology's treatment for chemotherapy-induced neutropenia.